Ambit Biosciences

Ambit Biosciences

Ambit Biosciences

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Founded
2000
Raised
$111M
Follow us
Alexa global traffic share
Acquired by
Daiichi Sankyo Co., Ltd.
29 Sep 2014
$410,000,000
Latest funding Show all
$50,000,000
Venture capital - 2012
$30,000,000
Venture capital (Series D) - 2011

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Ambit Biosciences makes some noise.